The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic characterization of anal canal squamous cell carcinoma (ASCC) and outcomes on matched targeted therapy.
 
Maliha Nusrat
Travel, Accommodations, Expenses - Takeda
(OPTIONAL) Uncompensated Relationships - Haymarket Media
 
Justin Jee
Patents, Royalties, Other Intellectual Property - Patient license, MDSeq Inc
 
Debyani Chakravarty
Consulting or Advisory Role - Medendi Medical Travel
 
David Pfister
Consulting or Advisory Role - MeiraGTx; Nykode Therapeutics
Research Funding - Akeso Biopharma; AstraZeneca (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Eisai (Inst); Hookipa Pharma (Inst); Lilly (Inst); MedImmune (Inst); MeiraGTx (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst)
 
Neil Segal
Consulting or Advisory Role - Agenus; AstraZeneca; Novartis; Numab; PureTech; Regeneron
Research Funding - AstraZeneca; Bristol Myers Squibb Foundation; Merck; Pfizer; Roche /Genentech
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Regeneron
 
Neal Rosen
Stock and Other Ownership Interests - BeiGene; eFFECTOR Therapeutics; Kura Oncology; Zai Lab
Consulting or Advisory Role - BeiGene; Jubilant Therapeutics; MapKure; Ribon Therapeutics
Research Funding - AstraZeneca; Boehringer Ingelheim; Pfizer; Revolution Medicines
Travel, Accommodations, Expenses - Plexxikon
Other Relationship - Chugai Pharma; eFFECTOR; Verastem
 
James Harding
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Cogent Medicine; Elevar Therapeutics; Exelixis; Jazz Pharmaceuticals; Merck; RayzeBio; SERVIER
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol Myers Squibb Foundation (Inst); Jazz Pharmaceuticals (Inst); Kinnate Biopharma (Inst); Lilly (Inst); Tvardi Therapeutics (Inst); yivvia (Inst); Zymeworks (Inst)
 
Rona Yaeger
Consulting or Advisory Role - Loxo@Lilly; Mirati Therapeutics; Revolution Medicines
Research Funding - Boehringer Ingelheim (Inst); Boundless Bio (Inst); Daiichi Sankyo/UCB Japan (Inst); Mirati Therapeutics (Inst); Pfizer (Inst)
 
David Kelsen
No Relationships to Disclose